Evidence map›Paper›PMID 38017582›Full record

ArticleImplementation science communications2023

The Longitudinal Implementation Strategy Tracking System (LISTS): feasibility, usability, and pilot testing of a novel method.

Justin D Smith, Wynne E Norton, Sandra A Mitchell, Christine Cronin, Michael J Hassett, Jennifer L Ridgeway, Sofia F Garcia, Raymond U Osarogiagbon, Don S Dizon, Jessica D Austin and 7 more

Open access · goldAbstract read
In one paragraph

Article in Implementation science communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
17.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 39 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 7 institutions in 1 country.

Justin D SmithDepartment of Population Health Sciences, School of Medicine, University of Utah, Spencer Fox Eccles, Salt Lake City, UT, USA. jd.smith@hsc.utah.edu.ORCID http://orcid.org/0000-0003-3264-8082
Wynne E NortonDivision of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
Sandra A MitchellDivision of Cancer Control and Population Sciences, National Cancer Institute, Bethesda, MD, USA.
Christine CroninDivision of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.
Michael J HassettDepartments of Medical Oncology and Quality & Patient Safety, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.
Jennifer L RidgewayRobert D. and Patricia E. Kern Center for the Science of Health Care Delivery and Division of Health Care Delivery Research, Mayo Clinic, Rochester, MN, USA.
Sofia F GarciaDepartments of Psychiatry and Behavioral Science and Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Raymond U OsarogiagbonMultidisciplinary Thoracic Oncology Program, Thoracic Oncology Research Group, Baptist Cancer Center, Memphis, TN, USA.
Don S DizonDivision of Hematology-Oncology, Department of Medicine, Legoretta Cancer Center, The Warren Alpert Medical School of Brown University, and Lifespan Cancer Institute, Providence, USA.
Jessica D AustinDivision of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Scottsdale, AZ, USA.
Whitney BattestilliCenter for Clinical Research Informatics, RTI International, Durham, NC, USA.
Joshua E RichardsonCenter for Health Informatics, RTI International, Research Triangle Park, Fayetteville, NC, USA.
Nathan K TeschRobert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN, USA.
David CellaDepartment of Medical Social Sciences, Northwestern University Feinberg School of Medicine and Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA.
Andrea L ChevilleDepartment of Physical Medicine and Rehabilitation, Mayo Clinic, Rochester, MN, USA.
Lisa D DiMartinoPeter O'Donnell Jr. School of Public Health, University of Texas Southwestern Medical Center, Dallas, TX, USA.
IMPACT Consortium
Mayo Clinic in Arizona · USNorthwestern University · USDana-Farber Cancer Institute · USNational Cancer Institute · USRTI International · USBrown University · USThe University of Texas Southwestern Medical Center · US

Funding

Northwestern University Clinical and Translational Science Institute (NUCATS)UL1TR001422 · NCATS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI D'AQUILA, RICHARD · 2015 to 2023
$56.8M
CTSA UM1 Program at University of UtahUM1TR004409 · NCATS · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI RACHEL HESS, Jennifer Juhl Majersik · 2023 to 2026
$21.9M
SIMPRO Research Center: Integration and Implementation of PROs for Symptom Management in Oncology PracticeUM1CA233080 · NCI · DANA-FARBER CANCER INST · PI HASSETT, MICHAEL JAMES, OSAROGIAGBON, RAYMOND U · 2018 to 2023
$9.1M
Enhanced, EHR-facilitated Cancer Symptom Control (E2C2) Pragmatic Clinical TrialUM1CA233033 · NCI · MAYO CLINIC ROCHESTER · PI CHEVILLE, ANDREA LYNNE · 2018 to 2018
$8.7M
Implementation and Evaluation of an Expanded Bilingual Electronic Symptom Management Program across a Multi-site, Fully-integrated Comprehensive Cancer CenterUM1CA233035 · NCI · NORTHWESTERN UNIVERSITY AT CHICAGO · PI CELLA, DAVID · 2018 to 2021
$8.1M
Coordinating Center for Research Centers for Improving Management of Symptoms During and Following Cancer TreatmentU24CA232980 · NCI · RESEARCH TRIANGLE INSTITUTE · PI ARDINI, MARY-ANNE · 2018 to 2023
$3.4M
NCATS NIH HHS UL1 TR001422NCATS NIH HHS UM1 TR004409NCI NIH HHS U24 CA232980NCI NIH HHS U24CA232980NCI NIH HHS UM1 CA233033NCI NIH HHS UM1CA233033NCI NIH HHS UM1 CA233035NCI NIH HHS UM1CA233035NCI NIH HHS UM1 CA233080NCI NIH HHS UM1CA233080
6 · The paper itself

Abstract

backgroundSystematic approaches are needed to accurately characterize the dynamic use of implementation strategies and how they change over time. We describe the development and preliminary evaluation of the Longitudinal Implementation Strategy Tracking System (LISTS), a novel methodology to document and characterize implementation strategies use over time.

methodsThe development and initial evaluation of the LISTS method was conducted within the Improving the Management of SymPtoms during And following Cancer Treatment (IMPACT) Research Consortium (supported by funding provided through the NCI Cancer Moonshot

resultsInitial evaluation of LISTS indicates that it is a feasible and acceptable method, with content validity, for characterizing and tracking the use of implementation strategies over time. Users of LISTS highlighted several opportunities for improving the method for use in future and more diverse implementation studies.

conclusionsThe LISTS method was developed collaboratively between researchers and practitioners to fill a research gap in systematically tracking implementation strategy use and modifications in research studies and other implementation efforts. Preliminary feedback from LISTS users indicate it is feasible and usable. Potential future developments include additional features, fewer data elements, and interoperability with alternative data entry platforms. LISTS offers a systematic method that encourages the use of common data elements to support data analysis across sites and synthesis across studies. Future research is needed to further adapt, refine, and evaluate the LISTS method in studies with employ diverse study designs and address varying delivery settings, health conditions, and intervention types.

Indexed as

Common data elementsImplementation strategiesMethodologyModificationsReportingSpecification

Identifiers

PMID38017582
PMCPMC10683230
OpenAlexW4389088466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.